RESTful Lookup — Test-Drive (2007 – 2026)

{
  "NDC": [
    {
      "NDCCode": "67046-277-20",
      "PackageDescription": "20 TABLET in 1 BLISTER PACK (67046-277-20)",
      "NDC11Code": "67046-0277-20",
      "ProductNDC": "67046-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Hydrochlorothiazide",
      "NonProprietaryName": "Hydrochlorothiazide",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20170928",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA040807",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "HYDROCHLOROTHIAZIDE",
      "StrengthNumber": "25",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2022-01-04",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20211231",
      "IndicationAndUsage": "Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.",
      "Description": "Hydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. It is chemically designated as 6-chloro-3,4-dihydro- 2H-1,2,4-benzothiadiazine- 7-sulfonamide 1,1-dioxide and has the following structural formula:. C 7H 8ClN 3O 4S 2                                                                                                   M.W. 297.74. Hydrochlorothiazide is a white, or practically white, crystalline powder which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet for oral administration contains 12.5 mg, 25 mg and 50 mg hydrochlorothiazide, USP. In addition, each tablet contains the following inactive ingredients: corn starch, dibasic calcium phosphate, lactose monohydrate, magnesium stearate, pregelatinized starch, and sodium starch glycolate.Tablets of 12.5 mg and 25 mg strengths also contain FD&C yellow #6."
    },
    {
      "NDCCode": "67046-277-07",
      "PackageDescription": "7 TABLET in 1 BLISTER PACK (67046-277-07)",
      "NDC11Code": "67046-0277-07",
      "ProductNDC": "67046-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Hydrochlorothiazide",
      "NonProprietaryName": "Hydrochlorothiazide",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20170928",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA040807",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "HYDROCHLOROTHIAZIDE",
      "StrengthNumber": "25",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2022-01-04",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20211231",
      "IndicationAndUsage": "Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.",
      "Description": "Hydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. It is chemically designated as 6-chloro-3,4-dihydro- 2H-1,2,4-benzothiadiazine- 7-sulfonamide 1,1-dioxide and has the following structural formula:. C 7H 8ClN 3O 4S 2                                                                                                   M.W. 297.74. Hydrochlorothiazide is a white, or practically white, crystalline powder which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet for oral administration contains 12.5 mg, 25 mg and 50 mg hydrochlorothiazide, USP. In addition, each tablet contains the following inactive ingredients: corn starch, dibasic calcium phosphate, lactose monohydrate, magnesium stearate, pregelatinized starch, and sodium starch glycolate.Tablets of 12.5 mg and 25 mg strengths also contain FD&C yellow #6."
    },
    {
      "NDCCode": "67046-277-14",
      "PackageDescription": "14 TABLET in 1 BLISTER PACK (67046-277-14)",
      "NDC11Code": "67046-0277-14",
      "ProductNDC": "67046-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Hydrochlorothiazide",
      "NonProprietaryName": "Hydrochlorothiazide",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20170928",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA040807",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "HYDROCHLOROTHIAZIDE",
      "StrengthNumber": "25",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2022-01-04",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20211231",
      "IndicationAndUsage": "Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.",
      "Description": "Hydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. It is chemically designated as 6-chloro-3,4-dihydro- 2H-1,2,4-benzothiadiazine- 7-sulfonamide 1,1-dioxide and has the following structural formula:. C 7H 8ClN 3O 4S 2                                                                                                   M.W. 297.74. Hydrochlorothiazide is a white, or practically white, crystalline powder which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet for oral administration contains 12.5 mg, 25 mg and 50 mg hydrochlorothiazide, USP. In addition, each tablet contains the following inactive ingredients: corn starch, dibasic calcium phosphate, lactose monohydrate, magnesium stearate, pregelatinized starch, and sodium starch glycolate.Tablets of 12.5 mg and 25 mg strengths also contain FD&C yellow #6."
    },
    {
      "NDCCode": "67046-277-15",
      "PackageDescription": "15 TABLET in 1 BLISTER PACK (67046-277-15)",
      "NDC11Code": "67046-0277-15",
      "ProductNDC": "67046-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Hydrochlorothiazide",
      "NonProprietaryName": "Hydrochlorothiazide",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20170928",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA040807",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "HYDROCHLOROTHIAZIDE",
      "StrengthNumber": "25",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2022-01-04",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20211231",
      "IndicationAndUsage": "Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.",
      "Description": "Hydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. It is chemically designated as 6-chloro-3,4-dihydro- 2H-1,2,4-benzothiadiazine- 7-sulfonamide 1,1-dioxide and has the following structural formula:. C 7H 8ClN 3O 4S 2                                                                                                   M.W. 297.74. Hydrochlorothiazide is a white, or practically white, crystalline powder which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet for oral administration contains 12.5 mg, 25 mg and 50 mg hydrochlorothiazide, USP. In addition, each tablet contains the following inactive ingredients: corn starch, dibasic calcium phosphate, lactose monohydrate, magnesium stearate, pregelatinized starch, and sodium starch glycolate.Tablets of 12.5 mg and 25 mg strengths also contain FD&C yellow #6."
    },
    {
      "NDCCode": "67046-277-21",
      "PackageDescription": "21 TABLET in 1 BLISTER PACK (67046-277-21)",
      "NDC11Code": "67046-0277-21",
      "ProductNDC": "67046-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Hydrochlorothiazide",
      "NonProprietaryName": "Hydrochlorothiazide",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20170928",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA040807",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "HYDROCHLOROTHIAZIDE",
      "StrengthNumber": "25",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2022-01-04",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20211231",
      "IndicationAndUsage": "Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.",
      "Description": "Hydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. It is chemically designated as 6-chloro-3,4-dihydro- 2H-1,2,4-benzothiadiazine- 7-sulfonamide 1,1-dioxide and has the following structural formula:. C 7H 8ClN 3O 4S 2                                                                                                   M.W. 297.74. Hydrochlorothiazide is a white, or practically white, crystalline powder which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet for oral administration contains 12.5 mg, 25 mg and 50 mg hydrochlorothiazide, USP. In addition, each tablet contains the following inactive ingredients: corn starch, dibasic calcium phosphate, lactose monohydrate, magnesium stearate, pregelatinized starch, and sodium starch glycolate.Tablets of 12.5 mg and 25 mg strengths also contain FD&C yellow #6."
    },
    {
      "NDCCode": "67046-277-28",
      "PackageDescription": "28 TABLET in 1 BLISTER PACK (67046-277-28)",
      "NDC11Code": "67046-0277-28",
      "ProductNDC": "67046-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Hydrochlorothiazide",
      "NonProprietaryName": "Hydrochlorothiazide",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20170928",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA040807",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "HYDROCHLOROTHIAZIDE",
      "StrengthNumber": "25",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2022-01-04",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20211231",
      "IndicationAndUsage": "Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.",
      "Description": "Hydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. It is chemically designated as 6-chloro-3,4-dihydro- 2H-1,2,4-benzothiadiazine- 7-sulfonamide 1,1-dioxide and has the following structural formula:. C 7H 8ClN 3O 4S 2                                                                                                   M.W. 297.74. Hydrochlorothiazide is a white, or practically white, crystalline powder which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet for oral administration contains 12.5 mg, 25 mg and 50 mg hydrochlorothiazide, USP. In addition, each tablet contains the following inactive ingredients: corn starch, dibasic calcium phosphate, lactose monohydrate, magnesium stearate, pregelatinized starch, and sodium starch glycolate.Tablets of 12.5 mg and 25 mg strengths also contain FD&C yellow #6."
    },
    {
      "NDCCode": "67046-277-30",
      "PackageDescription": "30 TABLET in 1 BLISTER PACK (67046-277-30)",
      "NDC11Code": "67046-0277-30",
      "ProductNDC": "67046-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Hydrochlorothiazide",
      "NonProprietaryName": "Hydrochlorothiazide",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20170928",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA040807",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "HYDROCHLOROTHIAZIDE",
      "StrengthNumber": "25",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2022-01-04",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20211231",
      "IndicationAndUsage": "Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.",
      "Description": "Hydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. It is chemically designated as 6-chloro-3,4-dihydro- 2H-1,2,4-benzothiadiazine- 7-sulfonamide 1,1-dioxide and has the following structural formula:. C 7H 8ClN 3O 4S 2                                                                                                   M.W. 297.74. Hydrochlorothiazide is a white, or practically white, crystalline powder which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet for oral administration contains 12.5 mg, 25 mg and 50 mg hydrochlorothiazide, USP. In addition, each tablet contains the following inactive ingredients: corn starch, dibasic calcium phosphate, lactose monohydrate, magnesium stearate, pregelatinized starch, and sodium starch glycolate.Tablets of 12.5 mg and 25 mg strengths also contain FD&C yellow #6."
    },
    {
      "NDCCode": "67046-277-60",
      "PackageDescription": "60 TABLET in 1 BLISTER PACK (67046-277-60)",
      "NDC11Code": "67046-0277-60",
      "ProductNDC": "67046-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Hydrochlorothiazide",
      "NonProprietaryName": "Hydrochlorothiazide",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20170928",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA040807",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "HYDROCHLOROTHIAZIDE",
      "StrengthNumber": "25",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2022-01-04",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20211231",
      "IndicationAndUsage": "Hydrochlorothiazide tablets are indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Hydrochlorothiazide tablets have also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Hydrochlorothiazide tablets are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.",
      "Description": "Hydrochlorothiazide is a diuretic and antihypertensive. It is the 3,4-dihydro derivative of chlorothiazide. It is chemically designated as 6-chloro-3,4-dihydro- 2H-1,2,4-benzothiadiazine- 7-sulfonamide 1,1-dioxide and has the following structural formula:. C 7H 8ClN 3O 4S 2                                                                                                   M.W. 297.74. Hydrochlorothiazide is a white, or practically white, crystalline powder which is slightly soluble in water, but freely soluble in sodium hydroxide solution. Each tablet for oral administration contains 12.5 mg, 25 mg and 50 mg hydrochlorothiazide, USP. In addition, each tablet contains the following inactive ingredients: corn starch, dibasic calcium phosphate, lactose monohydrate, magnesium stearate, pregelatinized starch, and sodium starch glycolate.Tablets of 12.5 mg and 25 mg strengths also contain FD&C yellow #6."
    },
    {
      "NDCCode": "10544-277-20",
      "PackageDescription": "20 TABLET in 1 BOTTLE (10544-277-20)",
      "NDC11Code": "10544-0277-20",
      "ProductNDC": "10544-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Naproxen",
      "NonProprietaryName": "Naproxen",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20091214",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA078250",
      "LabelerName": "Blenheim Pharmacal, Inc.",
      "SubstanceName": "NAPROXEN",
      "StrengthNumber": "375",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]",
      "Status": "Deprecated",
      "LastUpdate": "2019-09-21",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231",
      "IndicationAndUsage": "Carefully consider the potential benefits and risks of naproxen, naproxen sodium and other treatment options before deciding to use naproxen and naproxen sodium tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). Naproxen as naproxen or naproxen sodium tablets are indicated: : 1 For the relief of the signs and symptoms of rheumatoid arthritis , 2 For the relief of the signs and symptoms of osteoarthritis , 3 For the relief of the signs and symptoms of ankylosing spondylitis , 4 For the relief of the signs and symptoms of juvenile arthritis.",
      "Description": "Naproxen USP is a proprionic acid derivative related to the arylacetic acid group of nonsteroidal anti-inflammatory drugs. The chemical names for naproxen USP and naproxen sodium USP are (S)-6-methoxy-α-methyl-2-naphthaleneacetic acid and (S)-6-methoxy-α-methyl-2-naphthaleneacetic acid, sodium salt, respectively. Naproxen USP and naproxen sodium USP have the following structures, respectively:. Naproxen USP has a molecular weight of 230.26 and a molecular formula of C14H14O3. Naproxen sodium USP has a molecular weight of 252.23 and a molecular formula of C14H13NaO3. Naproxen USP is an odorless, white to off-white crystalline substance. It is lipid-soluble, practically insoluble in water at low pH and freely soluble in water at high pH. The octanol/water partition coefficient of naproxen USP at pH 7.4 is 1.6 to 1.8. Naproxen sodium USP is a white to creamy white, crystalline solid, freely soluble in water at neutral pH. Naproxen tablets USP are available as light orange colored tablets containing 250 mg of naproxen USP, light orange colored tablets containing 375 mg of naproxen USP and light orange colored tablets containing 500 mg of naproxen USP for oral administration. The inactive ingredients are microcrystalline cellulose, croscarmellose sodium, iron oxides, povidone and magnesium stearate. Naproxen sodium tablets USP are available as blue tablets containing 275 mg of naproxen sodium USP and as blue tablets containing 550 mg of naproxen sodium USP for oral administration. The inactive ingredients are croscarmellose sodium, colloidal silicon dioxide, povidone, magnesium stearate, microcrystalline cellulose and talc. The coating suspension for the naproxen sodium 275 mg tablet may contain Opadry blue 03F50544. The coating suspension for the naproxen sodium 550 mg tablet may contain Opadry blue 03F50544."
    },
    {
      "NDCCode": "43744-277-20",
      "PackageDescription": "15 g in 1 DRUM (43744-277-20)",
      "NDC11Code": "43744-0277-20",
      "ProductNDC": "43744-277",
      "ProductTypeName": "BULK INGREDIENT",
      "NonProprietaryName": "Diclofenac Sodium",
      "DosageFormName": "POWDER",
      "StartMarketingDate": "20120808",
      "EndMarketingDate": "20130624",
      "MarketingCategoryName": "BULK INGREDIENT",
      "LabelerName": "CBSCHEM LIMITED",
      "SubstanceName": "DICLOFENAC SODIUM",
      "StrengthNumber": "1",
      "StrengthUnit": "g/g",
      "Status": "Deprecated",
      "LastUpdate": "2014-02-04",
      "ListingRecordCertifiedThrough": "20130624"
    },
    {
      "NDCCode": "43744-277-22",
      "PackageDescription": "20 g in 1 DRUM (43744-277-22)",
      "NDC11Code": "43744-0277-22",
      "ProductNDC": "43744-277",
      "ProductTypeName": "BULK INGREDIENT",
      "NonProprietaryName": "Diclofenac Sodium",
      "DosageFormName": "POWDER",
      "StartMarketingDate": "20120808",
      "EndMarketingDate": "20130624",
      "MarketingCategoryName": "BULK INGREDIENT",
      "LabelerName": "CBSCHEM LIMITED",
      "SubstanceName": "DICLOFENAC SODIUM",
      "StrengthNumber": "1",
      "StrengthUnit": "g/g",
      "Status": "Deprecated",
      "LastUpdate": "2014-02-04",
      "ListingRecordCertifiedThrough": "20130624"
    },
    {
      "NDCCode": "49999-277-20",
      "PackageDescription": "20 TABLET in 1 BOTTLE, PLASTIC (49999-277-20)",
      "NDC11Code": "49999-0277-20",
      "ProductNDC": "49999-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Hydrocodone Bitartrate And Acetaminophen",
      "NonProprietaryName": "Hydrocodone Bitartrate And Acetaminophen",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20110205",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA040084",
      "LabelerName": "Lake Erie Medical DBA Quality Care Products LLC",
      "SubstanceName": "HYDROCODONE BITARTRATE; ACETAMINOPHEN",
      "StrengthNumber": "10; 650",
      "StrengthUnit": "mg/1; mg/1",
      "Pharm_Classes": "Opioid Agonist [EPC],Opioid Agonists [MoA]",
      "DEASchedule": "CIII",
      "Status": "Deprecated",
      "LastUpdate": "2016-03-11"
    },
    {
      "NDCCode": "51079-277-20",
      "PackageDescription": "100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-277-20)  > 1 TABLET in 1 BLISTER PACK (51079-277-01)",
      "NDC11Code": "51079-0277-20",
      "ProductNDC": "51079-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Propranolol Hydrochloride",
      "NonProprietaryName": "Propranolol Hydrochloride",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20110920",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA070213",
      "LabelerName": "UDL Laboratories, Inc.",
      "SubstanceName": "PROPRANOLOL HYDROCHLORIDE",
      "StrengthNumber": "10",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC]",
      "Status": "Deprecated",
      "LastUpdate": "2015-04-10"
    },
    {
      "NDCCode": "52584-277-01",
      "PackageDescription": "1 VIAL, MULTI-DOSE in 1 BAG (52584-277-01)  > 20 mL in 1 VIAL, MULTI-DOSE",
      "NDC11Code": "52584-0277-01",
      "ProductNDC": "52584-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Lidocaine Hydrochloride",
      "NonProprietaryName": "Lidocaine Hydrochloride Anhydrous",
      "DosageFormName": "INJECTION, SOLUTION",
      "RouteName": "INFILTRATION; PERINEURAL",
      "StartMarketingDate": "20100901",
      "EndMarketingDate": "20240301",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA088327",
      "LabelerName": "General Injectables & Vaccines, Inc",
      "SubstanceName": "LIDOCAINE HYDROCHLORIDE",
      "StrengthNumber": "20",
      "StrengthUnit": "mg/mL",
      "Pharm_Classes": "Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2023-01-03",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "StartMarketingDatePackage": "20100901",
      "EndMarketingDatePackage": "20230101",
      "SamplePackage": "N",
      "IndicationAndUsage": "Lidocaine Hydrochloride Injection, USP is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.",
      "Description": "Lidocaine Hydrochloride Injection, USP is a sterile, nonpyrogenic solution of lidocaine hydrochloride in water for injection for parenteral administration in various concentrations with characteristics as follows. Multiple-dose vials contain 0.1% of methylparaben added as preservative. May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. The pH is 6.5 (5.0 to 7.0). See HOW SUPPLIED section for various sizes and strengths. Lidocaine is a local anesthetic of the amide type. Lidocaine Hydrochloride, USP is chemically designated 2-(diethylamino)-N-(2,6-dimethylphenyl)-acetamide monohydrochloride monohydrate, a white powder freely soluble in water. The molecular weight is 288.82. It has the following structural formula. The semi-rigid vial used for the plastic vials is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The safety of the plastic has been confirmed by tests in animals according to USP biological standards for plastic containers. The container requires no vapor barrier to maintain the proper drug concentration."
    },
    {
      "NDCCode": "57687-277-20",
      "PackageDescription": "1 BOTTLE, DROPPER in 1 CARTON (57687-277-20)  > 20 mL in 1 BOTTLE, DROPPER",
      "NDC11Code": "57687-0277-20",
      "ProductNDC": "57687-277",
      "ProductTypeName": "HUMAN OTC DRUG",
      "ProprietaryName": "Bach Original Flower Remedies",
      "NonProprietaryName": "Scleranthus Annuus Whole",
      "DosageFormName": "SOLUTION",
      "RouteName": "ORAL",
      "StartMarketingDate": "20020101",
      "MarketingCategoryName": "UNAPPROVED HOMEOPATHIC",
      "LabelerName": "Nelson Bach USA Limited",
      "SubstanceName": "SCLERANTHUS ANNUUS WHOLE",
      "StrengthNumber": "5",
      "StrengthUnit": "[hp_X]/.095mL",
      "Status": "Active",
      "LastUpdate": "2020-06-24",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20261231",
      "StartMarketingDatePackage": "20020101",
      "SamplePackage": "N",
      "IndicationAndUsage": "For relief of naturally occurring simple nervous tension."
    },
    {
      "NDCCode": "69452-277-20",
      "PackageDescription": "100 TABLET in 1 BOTTLE (69452-277-20) ",
      "NDC11Code": "69452-0277-20",
      "ProductNDC": "69452-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Dexamethasone",
      "NonProprietaryName": "Dexamethasone",
      "DosageFormName": "TABLET",
      "RouteName": "ORAL",
      "StartMarketingDate": "20230801",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA217001",
      "LabelerName": "Bionpharma Inc.,",
      "SubstanceName": "DEXAMETHASONE",
      "StrengthNumber": "4",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]",
      "Status": "Active",
      "LastUpdate": "2025-03-07",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20261231",
      "StartMarketingDatePackage": "20230801",
      "SamplePackage": "N",
      "IndicationAndUsage": "Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; in infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis. Gastrointestinal diseases: To tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis. Hematologic disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults, pure red cell aplasia, and selected cases of secondary thrombocytopenia. Miscellaneous: Diagnostic testing of adrenocortical hyperfunction, trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy. Neoplastic diseases: For the palliative management of leukemias and lymphomas. Nervous system: Acute exacerbations of multiple sclerosis, cerebral edema associated with primary or metastatic brain tumor, craniotomy, or head injury. Ophthalmic diseases: Sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids. Renal diseases: To induce a diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus. Respiratory diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis. Rheumatic disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus.",
      "Description": "Dexamethasone tablets, USP, for oral administration, are supplied as 4 mg, and 6 mg. Inactive ingredients are corn starch, D&C yellow 10 (4 mg), FD&C blue 1 (6 mg), lactose monohydrate, and magnesium stearate. The molecular weight for dexamethasone is 392.5 g/mol. It is designated chemically as 9-fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione. The molecular formula is C 22H 29FO 5 and the structural formula is:. Dexamethasone, USP a synthetic adrenocortical steroid, is a white to almost-white, crystalline powder. It is stable in air. It is practically insoluble in water, very slightly soluble in ether, slightly soluble in methylene chloride and chloroform, and sparingly soluble in methanol, ethanol (96 %), acetone and 1,4 dioxane."
    },
    {
      "NDCCode": "72789-277-20",
      "PackageDescription": "20 CAPSULE in 1 BOTTLE, PLASTIC (72789-277-20) ",
      "NDC11Code": "72789-0277-20",
      "ProductNDC": "72789-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Doxycycline Hyclate",
      "NonProprietaryName": "Doxycycline Hyclate",
      "DosageFormName": "CAPSULE",
      "RouteName": "ORAL",
      "StartMarketingDate": "19860710",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA062676",
      "LabelerName": "PD-Rx Pharmaceuticals, Inc.",
      "SubstanceName": "DOXYCYCLINE HYCLATE",
      "StrengthNumber": "100",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Tetracycline-class Drug [EPC], Tetracyclines [CS]",
      "Status": "Active",
      "LastUpdate": "2026-07-21",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20271231",
      "StartMarketingDatePackage": "20221118",
      "SamplePackage": "N",
      "IndicationAndUsage": "To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline hyclate and other antibacterial drugs, doxycycline hyclate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
      "Description": "Doxycycline hyclate is an antibacterial drug synthetically derived from oxytetracycline, and is available as doxycycline hyclate (doxycycline hydrochloride hemiethanolate hemihydrate) capsules and tablets for oral administration. The chemical designation of this light-yellow crystalline powder is alpha-6-deoxy-5-oxytetracycline. Doxycycline has a high degree of lipoid solubility and a low affinity for calcium binding. It is highly stable in normal human serum. Doxycycline will not degrade into an epianhydro form. Doxycycline hyclate has the following structural formula. Each capsule for oral administration contains doxycycline hyclate equivalent to 50 mg or 100 mg doxycycline (anhydrous). Inactive ingredients for capsules are: anhydrous lactose, croscarmellose sodium, FD&C Blue #1, gelatin, magnesium stearate, microcrystalline cellulose, and titanium dioxide. Each tablet for oral administration contains doxycycline hyclate equivalent to 100 mg doxycycline. Inactive ingredients for tablets are: lactose monohydrate, carnauba wax, croscarmellose sodium, D&C Yellow #10 aluminum lake, FD&C Red #40 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polysorbate 80, and titanium dioxide."
    },
    {
      "NDCCode": "73069-277-51",
      "PackageDescription": "1 VIAL, MULTI-DOSE in 1 BOX (73069-277-51)  > 20 mL in 1 VIAL, MULTI-DOSE",
      "NDC11Code": "73069-0277-51",
      "ProductNDC": "73069-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Viatrexx-ki-ub",
      "NonProprietaryName": "Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone",
      "DosageFormName": "INJECTION",
      "RouteName": "INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS",
      "StartMarketingDate": "20190329",
      "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
      "LabelerName": "VIATREXX BIO INCORPORATED",
      "SubstanceName": "NITRIC ACID; SUCCINIC ACID; ESCHERICHIA COLI; BERBERIS VULGARIS ROOT; EQUISETUM HYEMALE; POTASSIUM NITRATE; BEEF KIDNEY; PORK KIDNEY; METHYL BLUE; ONONIS SPINOSA WHOLE; CLERODENDRANTHUS SPICATUS LEAF; CHONDRODENDRON TOMENTOSUM ROOT; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP; BOS TAURUS URETER; SUS SCROFA URETER; BOS TAURUS URINARY BLADDER; SUS SCROFA URINARY BLADDER; PROTEUS INCONSTANS; HIERACIUM PILOSELLA WHOLE; QUINHYDRONE",
      "StrengthNumber": "31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31",
      "StrengthUnit": "[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL",
      "Pharm_Classes": "Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2021-01-01",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20201231",
      "StartMarketingDatePackage": "20190506",
      "SamplePackage": "N"
    },
    {
      "NDCCode": "73069-277-52",
      "PackageDescription": "3 VIAL, MULTI-DOSE in 1 BOX (73069-277-52)  > 20 mL in 1 VIAL, MULTI-DOSE",
      "NDC11Code": "73069-0277-52",
      "ProductNDC": "73069-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Viatrexx-ki-ub",
      "NonProprietaryName": "Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone",
      "DosageFormName": "INJECTION",
      "RouteName": "INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS",
      "StartMarketingDate": "20190329",
      "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
      "LabelerName": "VIATREXX BIO INCORPORATED",
      "SubstanceName": "NITRIC ACID; SUCCINIC ACID; ESCHERICHIA COLI; BERBERIS VULGARIS ROOT; EQUISETUM HYEMALE; POTASSIUM NITRATE; BEEF KIDNEY; PORK KIDNEY; METHYL BLUE; ONONIS SPINOSA WHOLE; CLERODENDRANTHUS SPICATUS LEAF; CHONDRODENDRON TOMENTOSUM ROOT; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP; BOS TAURUS URETER; SUS SCROFA URETER; BOS TAURUS URINARY BLADDER; SUS SCROFA URINARY BLADDER; PROTEUS INCONSTANS; HIERACIUM PILOSELLA WHOLE; QUINHYDRONE",
      "StrengthNumber": "31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31",
      "StrengthUnit": "[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL",
      "Pharm_Classes": "Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2021-01-01",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20201231",
      "StartMarketingDatePackage": "20190506",
      "SamplePackage": "N"
    },
    {
      "NDCCode": "73069-277-53",
      "PackageDescription": "5 VIAL, MULTI-DOSE in 1 BOX (73069-277-53)  > 20 mL in 1 VIAL, MULTI-DOSE",
      "NDC11Code": "73069-0277-53",
      "ProductNDC": "73069-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Viatrexx-ki-ub",
      "NonProprietaryName": "Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone",
      "DosageFormName": "INJECTION",
      "RouteName": "INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS",
      "StartMarketingDate": "20190329",
      "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
      "LabelerName": "VIATREXX BIO INCORPORATED",
      "SubstanceName": "NITRIC ACID; SUCCINIC ACID; ESCHERICHIA COLI; BERBERIS VULGARIS ROOT; EQUISETUM HYEMALE; POTASSIUM NITRATE; BEEF KIDNEY; PORK KIDNEY; METHYL BLUE; ONONIS SPINOSA WHOLE; CLERODENDRANTHUS SPICATUS LEAF; CHONDRODENDRON TOMENTOSUM ROOT; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP; BOS TAURUS URETER; SUS SCROFA URETER; BOS TAURUS URINARY BLADDER; SUS SCROFA URINARY BLADDER; PROTEUS INCONSTANS; HIERACIUM PILOSELLA WHOLE; QUINHYDRONE",
      "StrengthNumber": "31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31",
      "StrengthUnit": "[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL",
      "Pharm_Classes": "Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2021-01-01",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20201231",
      "StartMarketingDatePackage": "20190506",
      "SamplePackage": "N"
    },
    {
      "NDCCode": "73069-277-54",
      "PackageDescription": "6 VIAL, MULTI-DOSE in 1 BOX (73069-277-54)  > 20 mL in 1 VIAL, MULTI-DOSE",
      "NDC11Code": "73069-0277-54",
      "ProductNDC": "73069-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Viatrexx-ki-ub",
      "NonProprietaryName": "Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone",
      "DosageFormName": "INJECTION",
      "RouteName": "INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS",
      "StartMarketingDate": "20190329",
      "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
      "LabelerName": "VIATREXX BIO INCORPORATED",
      "SubstanceName": "NITRIC ACID; SUCCINIC ACID; ESCHERICHIA COLI; BERBERIS VULGARIS ROOT; EQUISETUM HYEMALE; POTASSIUM NITRATE; BEEF KIDNEY; PORK KIDNEY; METHYL BLUE; ONONIS SPINOSA WHOLE; CLERODENDRANTHUS SPICATUS LEAF; CHONDRODENDRON TOMENTOSUM ROOT; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP; BOS TAURUS URETER; SUS SCROFA URETER; BOS TAURUS URINARY BLADDER; SUS SCROFA URINARY BLADDER; PROTEUS INCONSTANS; HIERACIUM PILOSELLA WHOLE; QUINHYDRONE",
      "StrengthNumber": "31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31",
      "StrengthUnit": "[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL",
      "Pharm_Classes": "Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2021-01-01",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20201231",
      "StartMarketingDatePackage": "20190506",
      "SamplePackage": "N"
    },
    {
      "NDCCode": "73069-277-55",
      "PackageDescription": "10 VIAL, MULTI-DOSE in 1 BOX (73069-277-55)  > 20 mL in 1 VIAL, MULTI-DOSE",
      "NDC11Code": "73069-0277-55",
      "ProductNDC": "73069-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Viatrexx-ki-ub",
      "NonProprietaryName": "Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone",
      "DosageFormName": "INJECTION",
      "RouteName": "INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS",
      "StartMarketingDate": "20190329",
      "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
      "LabelerName": "VIATREXX BIO INCORPORATED",
      "SubstanceName": "NITRIC ACID; SUCCINIC ACID; ESCHERICHIA COLI; BERBERIS VULGARIS ROOT; EQUISETUM HYEMALE; POTASSIUM NITRATE; BEEF KIDNEY; PORK KIDNEY; METHYL BLUE; ONONIS SPINOSA WHOLE; CLERODENDRANTHUS SPICATUS LEAF; CHONDRODENDRON TOMENTOSUM ROOT; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP; BOS TAURUS URETER; SUS SCROFA URETER; BOS TAURUS URINARY BLADDER; SUS SCROFA URINARY BLADDER; PROTEUS INCONSTANS; HIERACIUM PILOSELLA WHOLE; QUINHYDRONE",
      "StrengthNumber": "31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31",
      "StrengthUnit": "[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL",
      "Pharm_Classes": "Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2021-01-01",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20201231",
      "StartMarketingDatePackage": "20190506",
      "SamplePackage": "N"
    },
    {
      "NDCCode": "73069-277-56",
      "PackageDescription": "12 VIAL, MULTI-DOSE in 1 BOX (73069-277-56)  > 20 mL in 1 VIAL, MULTI-DOSE",
      "NDC11Code": "73069-0277-56",
      "ProductNDC": "73069-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Viatrexx-ki-ub",
      "NonProprietaryName": "Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone",
      "DosageFormName": "INJECTION",
      "RouteName": "INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS",
      "StartMarketingDate": "20190329",
      "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
      "LabelerName": "VIATREXX BIO INCORPORATED",
      "SubstanceName": "NITRIC ACID; SUCCINIC ACID; ESCHERICHIA COLI; BERBERIS VULGARIS ROOT; EQUISETUM HYEMALE; POTASSIUM NITRATE; BEEF KIDNEY; PORK KIDNEY; METHYL BLUE; ONONIS SPINOSA WHOLE; CLERODENDRANTHUS SPICATUS LEAF; CHONDRODENDRON TOMENTOSUM ROOT; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP; BOS TAURUS URETER; SUS SCROFA URETER; BOS TAURUS URINARY BLADDER; SUS SCROFA URINARY BLADDER; PROTEUS INCONSTANS; HIERACIUM PILOSELLA WHOLE; QUINHYDRONE",
      "StrengthNumber": "31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31",
      "StrengthUnit": "[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL",
      "Pharm_Classes": "Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2021-01-01",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20201231",
      "StartMarketingDatePackage": "20190506",
      "SamplePackage": "N"
    },
    {
      "NDCCode": "73069-277-57",
      "PackageDescription": "25 VIAL, MULTI-DOSE in 1 BOX (73069-277-57)  > 20 mL in 1 VIAL, MULTI-DOSE",
      "NDC11Code": "73069-0277-57",
      "ProductNDC": "73069-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Viatrexx-ki-ub",
      "NonProprietaryName": "Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone",
      "DosageFormName": "INJECTION",
      "RouteName": "INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS",
      "StartMarketingDate": "20190329",
      "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
      "LabelerName": "VIATREXX BIO INCORPORATED",
      "SubstanceName": "NITRIC ACID; SUCCINIC ACID; ESCHERICHIA COLI; BERBERIS VULGARIS ROOT; EQUISETUM HYEMALE; POTASSIUM NITRATE; BEEF KIDNEY; PORK KIDNEY; METHYL BLUE; ONONIS SPINOSA WHOLE; CLERODENDRANTHUS SPICATUS LEAF; CHONDRODENDRON TOMENTOSUM ROOT; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP; BOS TAURUS URETER; SUS SCROFA URETER; BOS TAURUS URINARY BLADDER; SUS SCROFA URINARY BLADDER; PROTEUS INCONSTANS; HIERACIUM PILOSELLA WHOLE; QUINHYDRONE",
      "StrengthNumber": "31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31",
      "StrengthUnit": "[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL",
      "Pharm_Classes": "Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2021-01-01",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20201231",
      "StartMarketingDatePackage": "20190506",
      "SamplePackage": "N"
    },
    {
      "NDCCode": "73069-277-58",
      "PackageDescription": "50 VIAL, MULTI-DOSE in 1 BOX (73069-277-58)  > 20 mL in 1 VIAL, MULTI-DOSE",
      "NDC11Code": "73069-0277-58",
      "ProductNDC": "73069-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Viatrexx-ki-ub",
      "NonProprietaryName": "Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone",
      "DosageFormName": "INJECTION",
      "RouteName": "INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS",
      "StartMarketingDate": "20190329",
      "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
      "LabelerName": "VIATREXX BIO INCORPORATED",
      "SubstanceName": "NITRIC ACID; SUCCINIC ACID; ESCHERICHIA COLI; BERBERIS VULGARIS ROOT; EQUISETUM HYEMALE; POTASSIUM NITRATE; BEEF KIDNEY; PORK KIDNEY; METHYL BLUE; ONONIS SPINOSA WHOLE; CLERODENDRANTHUS SPICATUS LEAF; CHONDRODENDRON TOMENTOSUM ROOT; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP; BOS TAURUS URETER; SUS SCROFA URETER; BOS TAURUS URINARY BLADDER; SUS SCROFA URINARY BLADDER; PROTEUS INCONSTANS; HIERACIUM PILOSELLA WHOLE; QUINHYDRONE",
      "StrengthNumber": "31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31",
      "StrengthUnit": "[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL",
      "Pharm_Classes": "Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2021-01-01",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20201231",
      "StartMarketingDatePackage": "20190506",
      "SamplePackage": "N"
    },
    {
      "NDCCode": "73069-277-59",
      "PackageDescription": "100 VIAL, MULTI-DOSE in 1 BOX (73069-277-59)  > 20 mL in 1 VIAL, MULTI-DOSE",
      "NDC11Code": "73069-0277-59",
      "ProductNDC": "73069-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Viatrexx-ki-ub",
      "NonProprietaryName": "Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone",
      "DosageFormName": "INJECTION",
      "RouteName": "INTRAMUSCULAR; INTRAVENOUS; PARENTERAL; SUBCUTANEOUS",
      "StartMarketingDate": "20190329",
      "MarketingCategoryName": "UNAPPROVED DRUG OTHER",
      "LabelerName": "VIATREXX BIO INCORPORATED",
      "SubstanceName": "NITRIC ACID; SUCCINIC ACID; ESCHERICHIA COLI; BERBERIS VULGARIS ROOT; EQUISETUM HYEMALE; POTASSIUM NITRATE; BEEF KIDNEY; PORK KIDNEY; METHYL BLUE; ONONIS SPINOSA WHOLE; CLERODENDRANTHUS SPICATUS LEAF; CHONDRODENDRON TOMENTOSUM ROOT; PLANTAGO MAJOR; SMILAX ORNATA ROOT; SOLIDAGO VIRGAUREA FLOWERING TOP; BOS TAURUS URETER; SUS SCROFA URETER; BOS TAURUS URINARY BLADDER; SUS SCROFA URINARY BLADDER; PROTEUS INCONSTANS; HIERACIUM PILOSELLA WHOLE; QUINHYDRONE",
      "StrengthNumber": "31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31; 31",
      "StrengthUnit": "[kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL; [kp_C]/mL",
      "Pharm_Classes": "Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Depigmenting Activity [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2021-01-01",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20201231",
      "StartMarketingDatePackage": "20190506",
      "SamplePackage": "N"
    },
    {
      "NDCCode": "76233-277-20",
      "PackageDescription": "10 VIAL, SINGLE-DOSE in 1 CARTON (76233-277-20)  > 15 mL in 1 VIAL, SINGLE-DOSE (76233-277-00) ",
      "NDC11Code": "76233-0277-20",
      "ProductNDC": "76233-277",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Piperacillin And Tazobactam",
      "NonProprietaryName": "Piperacillin And Tazobactam",
      "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "RouteName": "INTRAVENOUS",
      "StartMarketingDate": "20200724",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA203768",
      "LabelerName": "Laboratorio Reig Jofre Sa.",
      "SubstanceName": "PIPERACILLIN SODIUM; TAZOBACTAM SODIUM",
      "StrengthNumber": "3; .375",
      "StrengthUnit": "g/15mL; g/15mL",
      "Pharm_Classes": "Penicillin-class Antibacterial [EPC],Penicillins [CS],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC]",
      "Status": "Deprecated",
      "LastUpdate": "2021-07-28",
      "PackageNdcExcludeFlag": "N",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20211231",
      "StartMarketingDatePackage": "20200724",
      "SamplePackage": "N"
    },
    {
      "NDCCode": "67046-082-20",
      "PackageDescription": "20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (67046-082-20)",
      "NDC11Code": "67046-0082-20",
      "ProductNDC": "67046-082",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Bupropion Hydrochloride",
      "NonProprietaryName": "Bupropion Hydrochloride",
      "DosageFormName": "TABLET, FILM COATED, EXTENDED RELEASE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20170928",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA077284",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "BUPROPION HYDROCHLORIDE",
      "StrengthNumber": "150",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]",
      "Status": "Deprecated",
      "LastUpdate": "2020-01-01",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20191231",
      "IndicationAndUsage": "Bupropion hydrochloride extended-release tablets (XL) is an aminoketone antidepressant, indicated for the treatment of major depressive disorder (MDD) and prevention of seasonal affective disorder (SAD). Periodically reevaluate long-term usefulness for the individual patient.  (  1).",
      "Description": "Bupropion Hydrochloride Extended-Release Tablets USP (XL), an antidepressant of the aminoketone class, is chemically unrelated to tricyclic, tetracyclic, selective serotonin reuptake inhibitor, or other known antidepressant agents. Its structure closely resembles that of diethylpropion; it is related to phenylethylamines. It is designated as (±)-1-(3-chorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride. The molecular weight is 276.2. The molecular formula is C 13H 18ClNO·HCl. Bupropion hydrochloride powder is white, crystalline, and highly soluble in water. It has a bitter taste and produces the sensation of local anesthesia on the oral mucosa. The structural formula is:. Bupropion hydrochloride extended-release tablets (XL) are supplied for oral administration as 150 mg and 300 mg white to off-white extended-release tablets. Each tablet contains the labeled amount of bupropion hydrochloride and the inactive ingredients: dehydrated alcohol, ethylcellulose, hydrochloric acid, hydroxypropylcellulose, methacrylic acid copolymer, povidone, silicon dioxide, hydrogenated vegetable oil and ethyl alcohol. The tablets are printed with edible black ink. The insoluble shell of the extended-release tablet may remain intact during gastrointestinal transit and is eliminated in the feces. Meets USP Dissolution Test 8."
    },
    {
      "NDCCode": "67046-083-20",
      "PackageDescription": "20 CAPSULE in 1 BLISTER PACK (67046-083-20)",
      "NDC11Code": "67046-0083-20",
      "ProductNDC": "67046-083",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Clindamycin Hydrochloride",
      "NonProprietaryName": "Clindamycin Hydrochloride",
      "DosageFormName": "CAPSULE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20170920",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA065061",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "CLINDAMYCIN HYDROCHLORIDE",
      "StrengthNumber": "150",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS],Neuromuscular Blockade [PE]",
      "Status": "Deprecated",
      "LastUpdate": "2022-01-04",
      "ProductNdcExcludeFlag": "N",
      "ListingRecordCertifiedThrough": "20211231",
      "IndicationAndUsage": "Clindamycin hydrochloride capsules, USP are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin hydrochloride capsules, USP are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the WARNING box, before selecting clindamycin hydrochloride capsules, USP are the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Anaerobes: Serious respiratory tract infections such as empyema, anaerobic pneumonitis, and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection. Streptococci: Serious respiratory tract infections; serious skin and soft tissue infections. Staphylococci: Serious respiratory tract infections; serious skin and soft tissue infections. Pneumococci: Serious respiratory tract infections. Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. To reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin hydrochloride capsules, USP and other antibacterial drugs, clindamycin hydrochloride capsules, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
      "Description": "Clindamycin hydrochloride is the hydrated hydrochloride salt of clindamycin. Clindamycin is a semisynthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent compound lincomycin. Clindamycin hydrochloride capsules, USP contain clindamycin hydrochloride, USP equivalent to 150 mg or 300 mg of clindamycin. Inactive ingredients: 150 mg - black iron oxide, corn starch, D&C Yellow #10, FD&C Blue no. 1, gelatin, lactose monohydrate, magnesium stearate, potassium hydroxide, propylene glycol, shellac, talc, and titanium dioxide; 300 mg - black iron oxide, corn starch, FD&C Blue no. 1, gelatin, lactose monohydrate, magnesium stearate, potassium hydroxide, propylene glycol, shellac, talc, and titanium dioxide. The structural formula is represented below. C 18H 33ClN 2O 5SHCl M.W. 461.45. The chemical name for clindamycin hydrochloride is Methyl 7-chloro-6, 7, 8-trideoxy-6-(1-methyl- trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L- threo-α-D- galacto-octopyranoside monohydrochloride."
    },
    {
      "NDCCode": "67046-084-20",
      "PackageDescription": "20 CAPSULE in 1 BLISTER PACK (67046-084-20)",
      "NDC11Code": "67046-0084-20",
      "ProductNDC": "67046-084",
      "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
      "ProprietaryName": "Clindamycin Hydrochloride",
      "NonProprietaryName": "Clindamycin Hydrochloride",
      "DosageFormName": "CAPSULE",
      "RouteName": "ORAL",
      "StartMarketingDate": "20100809",
      "MarketingCategoryName": "ANDA",
      "ApplicationNumber": "ANDA063083",
      "LabelerName": "Contract Pharmacy Services-PA",
      "SubstanceName": "CLINDAMYCIN HYDROCHLORIDE",
      "StrengthNumber": "150",
      "StrengthUnit": "mg/1",
      "Pharm_Classes": "Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]",
      "Status": "Deprecated",
      "LastUpdate": "2019-09-21",
      "ProductNdcExcludeFlag": "E",
      "ListingRecordCertifiedThrough": "20171231",
      "IndicationAndUsage": "Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the WARNING box, before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin). Anaerobes: Serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis and postsurgical vaginal cuff infection. Streptococci: Serious respiratory tract infections; serious skin and soft tissue infections. Staphylococci: Serious respiratory tract infections; serious skin and soft tissue infections. Pneumococci: Serious respiratory tract infections. Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin. To reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin hydrochloride and other antibacterial drugs, clindamycin hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.",
      "Description": "Clindamycin hydrochloride is the hydrated hydrochloride salt of clindamycin. Clindamycin is a semisynthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent compound lincomycin. The chemical name for clindamycin hydrochloride is Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside monohydrochloride. The structural formula is represented below. Clindamycin Hydrochloride Capsules USP (equivalent to 150 mg or 300 mg clindamycin) contain the following inactive ingredients: anhydrous lactose, magnesium stearate, starch (corn) and talc. The capsule shells contain: D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, gelatin, silicon dioxide, sodium lauryl sulfate, and titanium dioxide. The 150 mg capsule shell also contains black iron oxide and yellow iron oxide."
    }
  ]
}
                    

{"NDC":[{"NDCCode":"67046-277-20","ProprietaryName":"Hydrochlorothiazide","NonProprietaryName":"Hydrochlorothiazide"},{"NDCCode":"67046-277-07","ProprietaryName":"Hydrochlorothiazide","NonProprietaryName":"Hydrochlorothiazide"},{"NDCCode":"67046-277-14","ProprietaryName":"Hydrochlorothiazide","NonProprietaryName":"Hydrochlorothiazide"},{"NDCCode":"67046-277-15","ProprietaryName":"Hydrochlorothiazide","NonProprietaryName":"Hydrochlorothiazide"},{"NDCCode":"67046-277-21","ProprietaryName":"Hydrochlorothiazide","NonProprietaryName":"Hydrochlorothiazide"},{"NDCCode":"67046-277-28","ProprietaryName":"Hydrochlorothiazide","NonProprietaryName":"Hydrochlorothiazide"},{"NDCCode":"67046-277-30","ProprietaryName":"Hydrochlorothiazide","NonProprietaryName":"Hydrochlorothiazide"},{"NDCCode":"67046-277-60","ProprietaryName":"Hydrochlorothiazide","NonProprietaryName":"Hydrochlorothiazide"},{"NDCCode":"10544-277-20","ProprietaryName":"Naproxen","NonProprietaryName":"Naproxen"},{"NDCCode":"43744-277-20","NonProprietaryName":"Diclofenac Sodium"},{"NDCCode":"43744-277-22","NonProprietaryName":"Diclofenac Sodium"},{"NDCCode":"49999-277-20","ProprietaryName":"Hydrocodone Bitartrate And Acetaminophen","NonProprietaryName":"Hydrocodone Bitartrate And Acetaminophen"},{"NDCCode":"51079-277-20","ProprietaryName":"Propranolol Hydrochloride","NonProprietaryName":"Propranolol Hydrochloride"},{"NDCCode":"52584-277-01","ProprietaryName":"Lidocaine Hydrochloride","NonProprietaryName":"Lidocaine Hydrochloride Anhydrous"},{"NDCCode":"57687-277-20","ProprietaryName":"Bach Original Flower Remedies","NonProprietaryName":"Scleranthus Annuus Whole"},{"NDCCode":"69452-277-20","ProprietaryName":"Dexamethasone","NonProprietaryName":"Dexamethasone"},{"NDCCode":"72789-277-20","ProprietaryName":"Doxycycline Hyclate","NonProprietaryName":"Doxycycline Hyclate"},{"NDCCode":"73069-277-51","ProprietaryName":"Viatrexx-ki-ub","NonProprietaryName":"Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone"},{"NDCCode":"73069-277-52","ProprietaryName":"Viatrexx-ki-ub","NonProprietaryName":"Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone"},{"NDCCode":"73069-277-53","ProprietaryName":"Viatrexx-ki-ub","NonProprietaryName":"Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone"},{"NDCCode":"73069-277-54","ProprietaryName":"Viatrexx-ki-ub","NonProprietaryName":"Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone"},{"NDCCode":"73069-277-55","ProprietaryName":"Viatrexx-ki-ub","NonProprietaryName":"Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone"},{"NDCCode":"73069-277-56","ProprietaryName":"Viatrexx-ki-ub","NonProprietaryName":"Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone"},{"NDCCode":"73069-277-57","ProprietaryName":"Viatrexx-ki-ub","NonProprietaryName":"Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone"},{"NDCCode":"73069-277-58","ProprietaryName":"Viatrexx-ki-ub","NonProprietaryName":"Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone"},{"NDCCode":"73069-277-59","ProprietaryName":"Viatrexx-ki-ub","NonProprietaryName":"Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone"},{"NDCCode":"76233-277-20","ProprietaryName":"Piperacillin And Tazobactam","NonProprietaryName":"Piperacillin And Tazobactam"},{"NDCCode":"67046-082-20","ProprietaryName":"Bupropion Hydrochloride","NonProprietaryName":"Bupropion Hydrochloride"},{"NDCCode":"67046-083-20","ProprietaryName":"Clindamycin Hydrochloride","NonProprietaryName":"Clindamycin Hydrochloride"},{"NDCCode":"67046-084-20","ProprietaryName":"Clindamycin Hydrochloride","NonProprietaryName":"Clindamycin Hydrochloride"}]}
                    

<NDCList><NDC><NDCCode>67046-277-20</NDCCode><ProprietaryName>Hydrochlorothiazide</ProprietaryName><NonProprietaryName>Hydrochlorothiazide</NonProprietaryName></NDC><NDC><NDCCode>67046-277-07</NDCCode><ProprietaryName>Hydrochlorothiazide</ProprietaryName><NonProprietaryName>Hydrochlorothiazide</NonProprietaryName></NDC><NDC><NDCCode>67046-277-14</NDCCode><ProprietaryName>Hydrochlorothiazide</ProprietaryName><NonProprietaryName>Hydrochlorothiazide</NonProprietaryName></NDC><NDC><NDCCode>67046-277-15</NDCCode><ProprietaryName>Hydrochlorothiazide</ProprietaryName><NonProprietaryName>Hydrochlorothiazide</NonProprietaryName></NDC><NDC><NDCCode>67046-277-21</NDCCode><ProprietaryName>Hydrochlorothiazide</ProprietaryName><NonProprietaryName>Hydrochlorothiazide</NonProprietaryName></NDC><NDC><NDCCode>67046-277-28</NDCCode><ProprietaryName>Hydrochlorothiazide</ProprietaryName><NonProprietaryName>Hydrochlorothiazide</NonProprietaryName></NDC><NDC><NDCCode>67046-277-30</NDCCode><ProprietaryName>Hydrochlorothiazide</ProprietaryName><NonProprietaryName>Hydrochlorothiazide</NonProprietaryName></NDC><NDC><NDCCode>67046-277-60</NDCCode><ProprietaryName>Hydrochlorothiazide</ProprietaryName><NonProprietaryName>Hydrochlorothiazide</NonProprietaryName></NDC><NDC><NDCCode>10544-277-20</NDCCode><ProprietaryName>Naproxen</ProprietaryName><NonProprietaryName>Naproxen</NonProprietaryName></NDC><NDC><NDCCode>43744-277-20</NDCCode><NonProprietaryName>Diclofenac Sodium</NonProprietaryName></NDC><NDC><NDCCode>43744-277-22</NDCCode><NonProprietaryName>Diclofenac Sodium</NonProprietaryName></NDC><NDC><NDCCode>49999-277-20</NDCCode><ProprietaryName>Hydrocodone Bitartrate And Acetaminophen</ProprietaryName><NonProprietaryName>Hydrocodone Bitartrate And Acetaminophen</NonProprietaryName></NDC><NDC><NDCCode>51079-277-20</NDCCode><ProprietaryName>Propranolol Hydrochloride</ProprietaryName><NonProprietaryName>Propranolol Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>52584-277-01</NDCCode><ProprietaryName>Lidocaine Hydrochloride</ProprietaryName><NonProprietaryName>Lidocaine Hydrochloride Anhydrous</NonProprietaryName></NDC><NDC><NDCCode>57687-277-20</NDCCode><ProprietaryName>Bach Original Flower Remedies</ProprietaryName><NonProprietaryName>Scleranthus Annuus Whole</NonProprietaryName></NDC><NDC><NDCCode>69452-277-20</NDCCode><ProprietaryName>Dexamethasone</ProprietaryName><NonProprietaryName>Dexamethasone</NonProprietaryName></NDC><NDC><NDCCode>72789-277-20</NDCCode><ProprietaryName>Doxycycline Hyclate</ProprietaryName><NonProprietaryName>Doxycycline Hyclate</NonProprietaryName></NDC><NDC><NDCCode>73069-277-51</NDCCode><ProprietaryName>Viatrexx-ki-ub</ProprietaryName><NonProprietaryName>Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone</NonProprietaryName></NDC><NDC><NDCCode>73069-277-52</NDCCode><ProprietaryName>Viatrexx-ki-ub</ProprietaryName><NonProprietaryName>Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone</NonProprietaryName></NDC><NDC><NDCCode>73069-277-53</NDCCode><ProprietaryName>Viatrexx-ki-ub</ProprietaryName><NonProprietaryName>Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone</NonProprietaryName></NDC><NDC><NDCCode>73069-277-54</NDCCode><ProprietaryName>Viatrexx-ki-ub</ProprietaryName><NonProprietaryName>Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone</NonProprietaryName></NDC><NDC><NDCCode>73069-277-55</NDCCode><ProprietaryName>Viatrexx-ki-ub</ProprietaryName><NonProprietaryName>Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone</NonProprietaryName></NDC><NDC><NDCCode>73069-277-56</NDCCode><ProprietaryName>Viatrexx-ki-ub</ProprietaryName><NonProprietaryName>Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone</NonProprietaryName></NDC><NDC><NDCCode>73069-277-57</NDCCode><ProprietaryName>Viatrexx-ki-ub</ProprietaryName><NonProprietaryName>Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone</NonProprietaryName></NDC><NDC><NDCCode>73069-277-58</NDCCode><ProprietaryName>Viatrexx-ki-ub</ProprietaryName><NonProprietaryName>Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone</NonProprietaryName></NDC><NDC><NDCCode>73069-277-59</NDCCode><ProprietaryName>Viatrexx-ki-ub</ProprietaryName><NonProprietaryName>Nitric Acid , Succinic Acid , Escherichia Coli , Berberis Vulgaris Root , Equisetum Hyemale , Potassium Nitrate , Beef Kidney , Pork Kidney , Methyl Blue , Ononis Spinosa Whole , Clerodendranthus Spicatus Leaf , Chondrodendron Tomentosum Root , Plantago Major , Smilax Regelii Root , Solidago Virgaurea Flowering Top , Bos Taurus Ureter , Sus Scrofa Ureter , Bos Taurus Urinary Bladder , Sus Scrofa Urinary Bladder , Proteus Inconstans , Hieracium Pilosella Whole And Quinhydrone</NonProprietaryName></NDC><NDC><NDCCode>76233-277-20</NDCCode><ProprietaryName>Piperacillin And Tazobactam</ProprietaryName><NonProprietaryName>Piperacillin And Tazobactam</NonProprietaryName></NDC><NDC><NDCCode>67046-082-20</NDCCode><ProprietaryName>Bupropion Hydrochloride</ProprietaryName><NonProprietaryName>Bupropion Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>67046-083-20</NDCCode><ProprietaryName>Clindamycin Hydrochloride</ProprietaryName><NonProprietaryName>Clindamycin Hydrochloride</NonProprietaryName></NDC><NDC><NDCCode>67046-084-20</NDCCode><ProprietaryName>Clindamycin Hydrochloride</ProprietaryName><NonProprietaryName>Clindamycin Hydrochloride</NonProprietaryName></NDC></NDCList>